Literature DB >> 26625306

Assessing the Physiological Cost of Active Videogames (Xbox Kinect) Versus Sedentary Videogames in Young Healthy Males.

Gillian Barry1, Daniel Tough2, Phillip Sheerin2, Oliver Mattinson2, Rachael Dawe2, Elisabeth Board2.   

Abstract

OBJECTIVES: The aims of this study were twofold: (1) to compare the physiological costs of active videogames (AVGs) and sedentary videogames (SVGs) and (2) to compare the exercise intensities attained during AVGs with the exercise intensity criteria for moderate and vigorous physical activity, as stated in current physical activity recommendations for improving public health.
MATERIALS AND METHODS: Nineteen young males participated in the study (age, 23 ± 3 years; height, 178 ± 6 cm; weight, 78 ± 15 kg). Participants completed a maximum oxygen uptake ([Formula: see text]) test and a gaming session, including AVGs ("Reflex Ridge," "River Rush," and "Boxing" for the Microsoft [Redmond, WA] Kinect™) and SVGs ("FIFA 14" [Electronic Arts, Burnaby, BC, Canada] and "Call of Duty" [Activision, Santa Monica, CA]). Heart rate (HR) and oxygen uptake [Formula: see text]) were recorded continuously during all videogames. Rating of perceived exertion (RPE) was taken every 3 minutes during AVGs and SVGs. Energy expenditure (EE), expressed as metabolic equivalents (METs), was calculated. One MET was defined as the volume of oxygen consumed at rest in a seated position and is equal to 3.5 mL of O2/kg of body mass/minute. The exercise intensity for each game was expressed as a percentage of [Formula: see text] and percentage of age-predicted maximum HR (HRmax).
RESULTS: Exercise intensity (percentage HRmax, percentage [Formula: see text], and RPE) and EE (METs) were significantly higher during active gaming compared with sedentary gameplay (P < 0.01). AVGs elicited moderate levels of exercise intensity (64-72 percent HRmax) in line with current recommended physical activity guidelines.
CONCLUSIONS: Our results indicate AVGs provoke physiological responses equivalent to a moderate-intensity physical activity.

Entities:  

Mesh:

Year:  2015        PMID: 26625306     DOI: 10.1089/g4h.2015.0036

Source DB:  PubMed          Journal:  Games Health J        ISSN: 2161-783X


  6 in total

1.  Exergaming (XBOX Kinect™) versus traditional gym-based exercise for postural control, flow and technology acceptance in healthy adults: a randomised controlled trial.

Authors:  Gillian Barry; Paul van Schaik; Alasdair MacSween; John Dixon; Denis Martin
Journal:  BMC Sports Sci Med Rehabil       Date:  2016-08-23

2.  Using Xbox kinect motion capture technology to improve clinical rehabilitation outcomes for balance and cardiovascular health in an individual with chronic TBI.

Authors:  Shane Chanpimol; Bryant Seamon; Haniel Hernandez; Michael Harris-Love; Marc R Blackman
Journal:  Arch Physiother       Date:  2017-05-31

Review 3.  Effectiveness of Exergaming in Improving Cognitive and Physical Function in People With Mild Cognitive Impairment or Dementia: Systematic Review.

Authors:  Yinan Zhao; Hui Feng; Xinyin Wu; Yan Du; Xiufen Yang; Mingyue Hu; Hongting Ning; Lulu Liao; Huijing Chen; Yishan Zhao
Journal:  JMIR Serious Games       Date:  2020-06-30       Impact factor: 4.143

4.  The feasibility, acceptability and outcomes of exergaming among individuals with cancer: a systematic review.

Authors:  Daniel Tough; Jonathan Robinson; Steven Gowling; Peter Raby; John Dixon; Samantha L Harrison
Journal:  BMC Cancer       Date:  2018-11-21       Impact factor: 4.430

5.  Acute Effects of Esports on the Cardiovascular System and Energy Expenditure in Amateur Esports Players.

Authors:  Rebecca T Zimmer; Sandra Haupt; Heiko Heidenreich; Walter F J Schmidt
Journal:  Front Sports Act Living       Date:  2022-03-11

6.  Virtual Reality Gaming Elevates Heart Rate but Not Energy Expenditure Compared to Conventional Exercise in Adult Males.

Authors:  Théo Perrin; Charles Faure; Kévin Nay; Giammaria Cattozzo; Anthony Sorel; Richard Kulpa; Hugo A Kerhervé
Journal:  Int J Environ Res Public Health       Date:  2019-11-11       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.